Literature DB >> 12001178

A randomized, placebo-controlled trial of paroxetine in nursing home residents with non-major depression.

Adam B Burrows1, Carl Salzman, Andrew Satlin, Kenneth Noble, Bruce G Pollock, Tamara Gersh.   

Abstract

Depression is common across a broad spectrum of severity among nursing home residents. Previous research has demonstrated the effectiveness of antidepressants in nursing home residents with major depression, but it is not known whether antidepressants are helpful in residents with less severe forms of depression. We conducted a randomized double-blind placebo-controlled 8-week trial comparing paroxetine and placebo in very old nursing home residents with non-major depression. The main outcome measure was the primary nurse's Clinical Impression of Change (CGI-C). Additional outcome measures were improvement on the interview-derived Hamilton Depression Rating Scale (HDRS) and Cornell Scale for Depression (CS) scores. Twenty-four subjects with a mean age of 87.9 were enrolled and twenty subjects completed the trial. Placebo response was high, and when all subjects were considered, there were no differences in improvement between the paroxetine and placebo groups. Two subjects that received paroxetine developed delirium, and subjects that received paroxetine were more likely to experience a decrease in Mini Mental State Exam scores (P =.03). There were no differences in serum anticholinergic activity between groups. In a subgroup analysis of 15 subjects with higher baseline HDRS and CS scores, there was a trend toward greater improvement in the paroxetine group in an outcome measure that combined the CGI-C and interview-based measures (P =.06). Paroxetine is not clearly superior to placebo in this small study of very old nursing home residents with non-major depression, and there is a risk of adverse cognitive effects. Because of the high placebo response and the trend towards improvement in the more severely ill patients, it is possible that a larger study would have demonstrated a significant therapeutic effect for paroxetine as compared with placebo. The study also illustrates the discordance between patient and caregiver ratings, and the difficulties in studying very elderly patients with mood disorders. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12001178     DOI: 10.1002/da.10014

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  12 in total

Review 1.  Tolerability of selective serotonin reuptake inhibitors: issues relevant to the elderly.

Authors:  Brian Draper; Karen Berman
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 2.  A review of the effectiveness of antidepressant medications for depressed nursing home residents.

Authors:  Richard D Boyce; Joseph T Hanlon; Jordan F Karp; John Kloke; Ahlam Saleh; Steven M Handler
Journal:  J Am Med Dir Assoc       Date:  2011-10-21       Impact factor: 4.669

Review 3.  Use of antidepressants in late-life depression.

Authors:  Tarek K Rajji; Benoit H Mulsant; Francis E Lotrich; Cynthia Lokker; Charles F Reynolds
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 4.  Use of antidepressants in older patients with co-morbid medical conditions: guidance from studies of depression in somatic illness.

Authors:  Gary J Kennedy; Paula Marcus
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 5.  Overuse of antidepressant drugs for the treatment of depression.

Authors:  Jon Jureidini; Anne Tonkin
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 6.  Treatment of depression in nursing home residents without significant cognitive impairment: a systematic review.

Authors:  Adam Simning; Kelsey V Simons
Journal:  Int Psychogeriatr       Date:  2016-10-19       Impact factor: 3.878

7.  Subthreshold depression in older subjects: an unmet therapeutic need.

Authors:  A Cherubini; G Nisticò; R Rozzini; R Liperoti; M Di Bari; E Zampi; L Ferrannini; E Aguglia; L Pani; R Bernabei; N Marchionni; M Trabucchi
Journal:  J Nutr Health Aging       Date:  2012-10       Impact factor: 4.075

Review 8.  Course and outcomes of depression in the elderly.

Authors:  Robert Kohn; Gary Epstein-Lubow
Journal:  Curr Psychiatry Rep       Date:  2006-02       Impact factor: 5.285

Review 9.  Depression in nursing homes: ensuring adequate treatment.

Authors:  Robert H Llewellyn-Jones; John Snowdon
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 10.  A systematic mapping review of randomized controlled trials (RCTs) in care homes.

Authors:  Adam L Gordon; Phillipa A Logan; Rob G Jones; Calum Forrester-Paton; Jonathan P Mamo; John R F Gladman
Journal:  BMC Geriatr       Date:  2012-06-25       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.